Literature DB >> 7425970

Macular oedema and retinal branch vein occlusion.

D V Greer, I J Constable, R L Cooper.   

Abstract

The visual prognosis of patients suffering from retinal branch vein occlusion complicated by macular oedema is assessed in relation to the degress of capillary fallout. Extensive retinal capillary fallout associated with macular oedema was found to confer a poor visual prognosis in a series of 89 patients followed for an average time of 14 months. If the degree of capillary fallout associated with marular oedema was minimal, the visual prognosis was considerably improved.

Entities:  

Mesh：

Year:  1980        PMID： 7425970     DOI： 10.1111/j.1442-9071.1980.tb00340.x

Source DB:  PubMed          Journal:  Aust J Ophthalmol        ISSN： 0310-1177


  18 in total

1.  Visual acuity and multifocal electroretinographic changes after arteriovenous crossing sheathotomy for macular edema associated with branch retinal vein occlusion.

Authors:  Eun Jee Chung; William R Freeman; Hyoung Jun Koh
Journal:  Retina       Date:  2008-02       Impact factor: 4.256

2.  Arteriovenous crossing sheathotomy versus intravitreal triamcinolone acetonide injection for treatment of macular edema associated with branch retinal vein occlusion.

Authors:  Eun Jee Chung; Hyo Lee; Hyoung Jun Koh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-04-19       Impact factor: 3.117

3.  Intravitreal triamcinolone acetonide versus bevacizumab therapy for macular edema associated with branch retinal vein occlusion.

Authors:  Yeo Jue Byun; Mi In Roh; Sung Chul Lee; Hyoung Jun Koh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-02-25       Impact factor: 3.117

4.  Repeatability of ganglion cell-inner plexiform layer thickness measurements using spectral-domain OCT in branch retinal vein occlusion.

Authors:  Yeon Hee Lee; Min-Su Kim; Seung Il Ahn; Hye Jin Park; Kyung Sup Shin; Jung-Yeul Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-06-11       Impact factor: 3.117

5.  Photopic negative response in branch retinal vein occlusion with macular edema.

Authors:  Hidetaka Noma; Tatsuya Mimura; Manami Kuse; Kanako Yasuda; Masahiko Shimura
Journal:  Int Ophthalmol       Date:  2014-11-11       Impact factor: 2.031

6.  Intravitreal bevacizumab vs. sham treatment in acute branch retinal vein occlusion with macular edema: results at 3 months (Report 1).

Authors:  Siamak Moradian; Hooshang Faghihi; Babak Sadeghi; Niloofar Piri; Hamid Ahmadieh; Masoud Soheilian; Mohammad Hossein Dehghan; Mohsen Azarmina; Mohammad Riazi Esfahani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-08-18       Impact factor: 3.117

7.  Spectral-domain optical coherence tomography (SD-OCT) patterns and response to intravitreal bevacizumab therapy in macular edema associated with branch retinal vein occlusion.

Authors:  Hae Min Kang; Eun Jee Chung; Yong Min Kim; Hyoung Jun Koh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-06-01       Impact factor: 3.117

8.  Combined intravitreal triamcinolone injection and laser photocoagulation in eyes with persistent macular edema after branch retinal vein occlusion.

Authors:  Juliane Riese; Vlassis Loukopoulos; Cornelia Meier; Melanie Timmermann; Heinrich Gerding
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-08-16       Impact factor: 3.117

9.  Retinal branch vein occlusion: a study of argon laser photocoagulation in the treatment of macular oedema.

Authors:  J S Shilling; C A Jones
Journal:  Br J Ophthalmol       Date:  1984-03       Impact factor: 4.638

10.  Prognostic factors for visual outcome after intravitreal bevacizumab for macular edema due to branch retinal vein occlusion.

Authors:  Eun Jee Chung; Young Taek Hong; Sung Chul Lee; Oh Woong Kwon; Hyoung Jun Koh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-06-11       Impact factor: 3.117
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.